Anxiolytic-like actions of toluene in the burying behavior and plus-maze tests: Differences in sensitivity between 5-HT(1B) knockout and wild-type mice

Behavioural Brain Research

Volumn 115, Issue 1, 2000, Pages 85-94

  López Rubalcava, Carolina ^a,b   Hen, Rene ^c   Cruz, Silvia Lorenia ^a  

^a Secc de Terap Experimental   (Mexico)

^b Div de Invest en Neurociencias   (Mexico)

^c Howard Hughes Medical Institute   (United States)

Author keywords

5 HT(1B) knockout mice; Anxiety; Burying behavior; Elevated plus maze; Toluene

Indexed keywords

SEROTONIN 1B RECEPTOR; TOLUENE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TOXICOKINETICS; TRANQUILIZING ACTIVITY;

ANIMAL; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EQUILIBRIUM; MALE; MICE; MICE, KNOCKOUT; PAIN MEASUREMENT; REACTION TIME; RECEPTORS, SEROTONIN; SUPPORT, NON-U.S. GOV'T; TOLUENE;

EID: 0342844339     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00241-2     Document Type: Article

References (61)

1. Adamec R.E., Burton P., Shallow T., Budgell J. Unilateral block of NMDA receptors in the amigdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle-effective hemisphere depends on the behavior. Physiol. Behav. 65:1999;739-751.
2. Arito H., Tsuruta H., Nkagaki K. Acute effects of toluene on circadian rhythms of sleep-wakefulness and brain monoamine metabolism in rats. Toxicology. 33:1984;291-301.
3. Arlien-Søborg P. Solvent Neurotoxicity. 1992;61-106 CRC Press, Boca Raton, FL.
4. Bale AS, Cruz SL, Balster RL, Woodward JJ. Effects of toluene on nicotinic acetylcholine receptors expressed in Xenopus oocytes. College on problems of drug dependence. Abstracts of the 61st Annual Scientific meeting 1999, p. 7.
5. Beckstead M.J., Weiner J.L., Mihic J.J. Comparisons of the effects of ethanol and inhaled drugs of abuse on GABAa, glycine and serotonin-3 receptors. Alcohol. Clin. Exp. Ther. Res. 23S:1999;12A.
6. Belzung C., Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav. Pharmacol. 8:1997;541-548.
7. 1B receptors in the rat brain. Eur. J. Pharmacol. 294:1995;531-540.
8. Bowen SE, Balster RL. The effects of abused inhalants on locomotor activity in mice. In: Harris LS, editors. Proceedings of the 56th Annual Scientific Meeting, Vol. 2, National Institute on Drug Abuse Monograph 153. U.S. Department of Health and Human Services, Rockville,MD, 1994, 426.
9. Bowen S.E., Wiley J.L., Balster R.L. The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur. J. Pharmacol. 312:1996;131-136.
10. Bowen S.E., Balster R.L. A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp. Clin. Psychopharmacol. 6:1998;235-247.
11. Bowen S.E., Wiley J.L., Jones H.E., Balster R.L. Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp. Clin. Psychopharmacol. 7:1999;28-37.
12. Brunner D., Hen R. Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann. New York Acad. Sci. 836:1997;81-105.
13. 1B knockout mice. Behav. Neurosci. 113:1999;587-601.
14. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
15. Crabbe J.C., Phillips T.J., Feller D.J., Hen R., Wenger C.D., Lessoc C.N., Schafer G.L. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat. Genet. 14:1996;98-101.
16. Cruz S.L., Tooraj M., Thomas B., Balster R.L., Woodward J.J. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 286:1998;334-340.
17. Cruz SL, Páez-Martinez N, Pellicer F, López-Rubalcava C. Toluene increases acute thermonociception in mice. Behav Brain Res, submitted.
18. De Boer S.F., Van der Gugten J., Slangen J.L. Behavioral and hormonal indices of anxiolytic and anxiogenic drug action in the shock prod defensive burying/avoidance paradigm. Olivier B., Mos J., Slangen J.L. Animal Models in Psychopharmacology. 1991;81-96 Birkhauser, Basel, Switzerland.
19. Echeverria D., Fine L., Langolf G., Schork T., Sampaio C. Acute behavioural comparisons of toluene and ethanol in human subjects. Br. J. Ind. Med. 48:1991;750-761.
20. 1B binding sites. Arch. Pharmacol. 332:1986;1-7.
21. 1A compounds by GABA-benzodiazepine agents in rats. Pharmacol. Biochem. Behav. 60:1998;27-32.
22. Fernández-Guasti A., Picazo O. The actions of diazepam and serotonergic anxiolytics vary according to the gender and estrous cycle phase. Pharmacol. Biochem. Behav. 37:1990;77-81.
23. File S.E. Psychopharmacology of Anxiolytics and Antidepressants. 1991;Pergamon Press, New York.
24. Geller I., Hartmann R.J., Randle S.R., Gause E.M. Toluene inhalation and anxiolytic activity: possible synergism with diazepam. Pharmacol. Biochem. Behav. 19:1983;899-903.
25. Grant K.A. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5:1994;383-404.
26. Harel-Dupas C., Cloez I., Fillion G. The inhibitory effect of trifluoromethylphenylpiperazine on [3H] acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine-1 receptor distinct from 1A, 1B and 1C subtypes. J. Neurochem. 56:1991;221-227.
27. Harrison A.A., Parsons L.H., Koob G.F., Markou A. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Psychopharmacology. 141:1999;242-250.
28. B synaptic potential in rat dopamine neurons. J. Neurosci. 12:1992;2000-2006.
29. Knisely J.S., Rees D., Balster R.L. Discriminative stimulus properties of toluene in the rat. Neurotoxicol. Teratol. 12:1990;129-1333.
30. Kozel N, Sloboda Z, De la Rosa M. Epidemiology of Inhalant Abuse: An International Perspective. NIDA Res. Monograph 148. 1995;317 U.S. Department of Health and Human Services, Rockville, MD.
31. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
32. 1A agonists. Behav. Pharmacol. 5:1994;42-51.
33. 1A compounds in mice depends on the anxiety paradigm. Pharmacol. Biochem. Behav. 54:1996;677-686.
34. Lorenzana-Jimenez M, Magos-Guerrero GA, Campos-Sepulveda AE, Salas M. Effects of acute exposure to toluene on GABA concentrations in the brain and cerebellum of adult rats. College on problems of drug dependence. Abstracts of the 61st Annual Scientific Meeting, 1999, p. 89.
35. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 243:1989;1721-1724.
36. Maura G., Raiteri M. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetyl-choline release. Eur. J. Pharmacol. 129:1986;333-337.
37. Pellicer F, López-Rubalcava C, Cruz SL, Toluene induces an increase in thermonociception in mice. College on problems of drug dependence. Abstracts of the 61st Annual Scientific Meeting, 1999, p. 120.
38. Pellow S., Johnston A.L., File S.E. Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J. Pharm. Pharmacol. 39:1987;917-928.
39. Pinel J.B.J., Treit D. Burying as a defensive response in rats. J. Comp. Physiol. Psychol. 92:1978;708-712.
40. Press E., Done A.K. Solvent sniffing. Physiologic effects and community control measures for intoxication from the intentional inhalation of organic solvents II. Pediatrics. 39:1967;611-622.
41. Raiteri M., Maura G., Bonanno G., Pittaluga A. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther. 237:1986;644-648.
42. Rea T.M., Nash J.F., Zabik J.E., Born G.S., Kessler W.V. Effects of toluene inhalation on brain biogenic amines in the rat. Toxicology. 31:1984;143-150.
43. Rees D.C., Coggeshall E., Balster R.L. Inhaled toluene produces pentobarbital-like discriminative stimulus effects in mice. Life Sci. 37:1985;1319-1325.
44. Rees D.C., Knisely J.S., Breen T.J., Balster R.L. Toluene, halothane, 1,1,1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J. Pharmacol. Exp. Ther. 243:1987;931-937.
45. Riegel A.C., French E.D. Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacol. Biochem. Behav. 62:1999;399-402.
46. Rocha B.A., Ator R., Emmett-Oglesby M.W., Hen R. Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol. Biochem. Behav. 57:1997;407-412.
47. Rodgers R.J., Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. Cooper S.J., Hendrie C.A. Ethology and Psychopharmacology. 1994;9-44 Wiley, Chichester, UK.
48. Rodgers R.J., Cole J.C., Aboualfa K., Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;805-813.
49. Rodríguez-Manzo G., López Rubalcava C., Fernández-Guasti A. Anxiolytic-like effect of ejaculation under various sexual behavior conditions in the male rat. Physiol. Behav. 67:1999;651-657.
50. Scearce-Levie K., Chen J.P., Gardner E., Hen R. 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders. Ann. New York Acad. Sci. 868:1999a;701-715.
51. 1B receptor. Psychopharmacology. 141:1999b;154-161.
52. Spiller H.A., Krenzelok E.P. Epidemiology of inhalant abuse reported to two regional poison centers. J. Toxicol. Clin. Toxicol. 35:1997;167-173.
53. Stengard K.G., Tham R., O'Connor W., Hoglund G., Ungerstedt U. Acute toluene increases extracellular GABA in the cerebellum of rat: a microdialysis study. Pharmacol. Toxicol. 73:1993;315-318.
54. Tegeris J.S., Balster R.L. A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam. Applied. Toxicol. 22:1994;240-250.
55. Treit D. Animal models for the study of antianxiety agents: a review. Neurosci. Biobehav. Rev. 9:1985;203-222.
56. Tsuda A., Tanaka M., Georgiev V., Emoto H. Effects of angiotensin II on behavioral responses on defensive burying paradigm in rats. Pharmacol. Biochem. Behav. 43:1992;729-732.
57. Wiley J.L., Compton A.D., Holcomb J.D., McCallum S.E., Varvel S.A., Porter J.H., Balster R.L. Effects of modulation of NMDA neurotransmission on response rate and duration in a conflict procedure in rats. Neuropharmacology. 37:1998;1527-1534.
58. Wood R.W., Coleman J.B., Schuler R., Cox C. Anticonvulsant and antipunishment effects of toluene. J. Pharmacol. Exp. Ther. 230:1984;407-412.
59. Woolverton W.L., Balster R.L. Behavioral and lethal effects of combinations of oral ethanol and inhaled 1,1,1-trichloroethane in mice. Toxicol. Appl. Pharmacol. 59:1981;1-7.
60. Yaksh T.L. Preclinical models of nociception. Yaksh T.L. Anesthesia: Biological Foundations. 1997;685-718 Lippincott-Raven, Philadelphia, USA.
61. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain. 16:1983;109-110.